NIOX Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for NIOX Group and similar public comparables like 908 Devices, Voxel, Semler Scientific, Carlsmed and more.

NIOX Group Overview

About NIOX Group

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.


Founded

2006

HQ

United Kingdom

Employees

91

Website

niox.com

Financials (LTM)

Revenue: $66M
EBITDA: $23M

EV

$303M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

NIOX Group Financials

NIOX Group reported last 12-month revenue of $66M and EBITDA of $23M.

In the same LTM period, NIOX Group generated $23M in EBITDA and $12M in net income.

Revenue (LTM)


NIOX Group P&L

In the most recent fiscal year, NIOX Group reported revenue of $65M and EBITDA of $22M.

NIOX Group is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 34%, and net margin of 14%.

See analyst estimates for NIOX Group
LTMLast FY202320242025202620272028
Revenue$66M$65M$49M$56M$65M
Gross Profit-$45M$35M$40M$45M
Gross Margin-69%72%72%69%
EBITDA$23M$22M$12M$16M$20M
EBITDA Margin35%34%23%29%31%
EBIT Margin24%22%13%18%22%
Net Profit$12M$9M$14M$5M$9M
Net Margin19%14%29%9%14%

Financial data powered by Morningstar, Inc.

NIOX Group Stock Performance

NIOX Group has current market cap of $328M, and enterprise value of $303M.

Market Cap Evolution


NIOX Group's stock price is $0.78.

NIOX Group share price decreased by 1.3% in the last 30 days, and by 16.9% in the last year.

NIOX Group has an EPS (earnings per share) of $0.02.

See more trading valuation data for NIOX Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$303M$328M0.3%-1.3%-15.0%-16.9%$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

NIOX Group Valuation Multiples

NIOX Group trades at 4.6x EV/Revenue multiple, and 13.2x EV/EBITDA.

See NTM and 2027E valuation multiples for NIOX Group

EV / Revenue (LTM)


NIOX Group Financial Valuation Multiples

As of July 6, 2026, NIOX Group has market cap of $328M and EV of $303M.

NIOX Group has a P/E ratio of 26.4x.

LTMLast FY202320242025202620272028
EV/Revenue4.6x4.6x6.1x5.4x4.6x
EV/EBITDA13.2x13.6x26.3x18.7x14.8x
EV/EBIT19.2x21.1x49.1x29.4x21.1x
EV/Gross Profit-6.7x8.5x7.5x6.7x
P/E26.4x35.0x22.9x66.2x35.0x
EV/FCF14.8x14.9x20.0x14.0x16.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified NIOX Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

NIOX Group Margins & Growth Rates

NIOX Group grew revenue by 3% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, NIOX Group reported gross margin of 69%, EBITDA margin of 34%, and net margin of 14%.

See estimated margins and future growth rates for NIOX Group

NIOX Group Margins

Last FY202420252026202720282029
Gross Margin69%72%69%73%
EBITDA Margin34%29%31%35%
EBIT Margin22%18%22%25%
Net Margin14%9%14%23%
FCF Margin31%39%29%31%

NIOX Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%14%17%3%
Gross Profit Growth8%14%12%8%
EBITDA Growth5%41%26%14%
EBIT Growth20%67%39%20%
Net Profit Growth64%(65%)89%64%
FCF Growth1%43%(14%)11%

Data powered by FactSet, Inc. and Morningstar, Inc.

NIOX Group Operational KPIs

NIOX Group's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.

NIOX Group's Rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

NIOX Group's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for NIOX Group
LTMLast FY202320242025202620272028
Rule of 4040%38%---
Bessemer Rule of X49%43%---
Revenue per Employee-$0.7M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue-23%30%27%23%
G&A Expenses to Revenue-18%23%21%18%
R&D Expenses to Revenue-5%6%6%5%
Opex to Revenue-47%60%54%47%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

NIOX Group Competitors

NIOX Group competitors include 908 Devices, Voxel, Semler Scientific, Carlsmed, Advanced Technology Company, Medios, OraSure, Standard BioTools, Abbott Pakistan and Sight Sciences.

Most NIOX Group public comparables operate across Medical Devices, Medical Imaging & Diagnostics, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
908 Devices3.9x3.5x(23.1x)(28.5x)
Voxel2.3x2.4x7.2x7.3x
Semler Scientific----
Carlsmed4.5x3.6x(8.2x)(7.3x)
Advanced Technology Company1.9x-149.5x-
Medios0.2x0.2x4.7x4.6x
OraSure1.2x1.2x(3.2x)(3.4x)
Standard BioTools(0.8x)(0.8x)1.1x1.8x

This data is available for Pro users. Sign up to see all NIOX Group competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About NIOX Group

When was NIOX Group founded?NIOX Group was founded in 2006.
Where is NIOX Group headquartered?NIOX Group is headquartered in United Kingdom.
How many employees does NIOX Group have?As of today, NIOX Group has over 91 employees.
Who is the CEO of NIOX Group?NIOX Group's CEO is Jonathan Charles Emms.
Is NIOX Group publicly listed?Yes, NIOX Group is a public company listed on London Stock Exchange.
What is the stock symbol of NIOX Group?NIOX Group trades under NIOX ticker.
When did NIOX Group go public?NIOX Group went public in 2014.
Who are competitors of NIOX Group?NIOX Group main competitors include 908 Devices, Voxel, Semler Scientific, Carlsmed, Advanced Technology Company, Medios, OraSure, Standard BioTools, Abbott Pakistan, Sight Sciences.
What is the current market cap of NIOX Group?NIOX Group's current market cap is $328M.
What is the current revenue of NIOX Group?NIOX Group's last 12 months revenue is $66M.
What is the current revenue growth of NIOX Group?NIOX Group revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of NIOX Group?Current revenue multiple of NIOX Group is 4.6x.
What is the current EBITDA of NIOX Group?NIOX Group's last 12 months EBITDA is $23M.
What is NIOX Group's EBITDA margin?NIOX Group's last 12 months EBITDA margin is 35%.
What is the current EV/EBITDA multiple of NIOX Group?Current EBITDA multiple of NIOX Group is 13.2x.
What is the current FCF of NIOX Group?NIOX Group's last 12 months FCF is $20M.
What is NIOX Group's FCF margin?NIOX Group's last 12 months FCF margin is 31%.
What is the current EV/FCF multiple of NIOX Group?Current FCF multiple of NIOX Group is 14.8x.
How many companies NIOX Group has acquired to date?NIOX Group hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies NIOX Group has invested to date?NIOX Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to NIOX Group

Lists including NIOX Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial